Titlebook: Nanovaccines; An Innovative Techno Sergio Rosales-Mendoza,Omar González-Ortega Book 2019 Springer Nature Switzerland AG 2019 Vaccinology.Ga

缺陷

摸索

Chitosan-Based Mucosal Nanovaccines,th many of them being highly immunogenic when administered by mucosal routes, which are the most attractive approach for massive and painless immunization. Clinical evaluation of some chitosan-based adjuvants adds potential to this field.

賠償

Liposome-Based Nanovaccines,of liposomes to enhance cellular and humoral responses. Therefore, liposomes are effective nanoparticles and the outstanding findings from the preclinical evaluation of many mucosal vaccine candidates indicate that there is a good prospect for the initiation of clinical trials in the coming years. T

OFF

Virus-Like Particles-Based Mucosal Nanovaccines, comprise the expansion of the use of low-cost platforms such as plants and bacteria, the development of multiepitopic/multivalent vaccines, and computationally designed VLPs. Mucosal VLPs-based vaccines stand as a major promising approach in vaccinology and the initiation of more clinical trials is

HACK

OASIS

Book 2019are easy to administer (promoting patient′s comfort and increasing compliance), allow triggering relevant immune responses at both the site of administration and distant compartments, and thus may protect the main entry portal for pathogens (oral, nasal, and genital mucosae). In this context, the po

設(shè)施

瘋狂

集合

978-3-030-31670-9Springer Nature Switzerland AG 2019

CANDY